About IBUB

Created in September 2006, the Institute of Biomedicine of the University of Barcelona (IBUB) conducts basic research and provides an interactive framework for scientists from different fields to conduct multidisciplinary integrated research in biomedicine.

Presentation and mission

IBUB’s objectives

Generate knowledge of biological systems using an integrative approach to identify objectives in therapy and the design of bioactive molecules with therapeutic potential.

Generate advances in the quality of the community’s living standards and of public health, promoting this at an international level and with a framework based on sustainability and high ethical standards.

Act as a quality centre for biomedical research training, so maintaining the Institute’s founding mission as an entity that brings together UB researchers from the university’s Faculties of Biology, Chemistry and Pharmacy and Food Sciences.

Governance
structure

IBUB’s personnel

The Institute is directed by the IBUB Management Council, which consists of a director accompanied by a standing committee of assessors, representatives of the Institute’s researchers, and representatives of other IBUB personnel. The Institute also has a Scientific Council formed by leading scientists in the field of biomedicine who act as external assessors of the IBUB’s scientific activities.

Location

Barcelona

The IBUB is located in the city of Barcelona in Pedrables, on the University of Barcelona’s Diagonal Campus Gateway to Knowledge—the area of Barcelona that is home to the highest concentration of research activity and knowledge transfer in Southern Europe. The Institute’s activities are conducted within the complex that includes the UB’s Scientific and Technical Services (SCT), the Barcelona Science Park, the research centres of the Technical University of Catalonia, and the UB’s own faculties for experimental and life sciences. Today, this part of the city is a focal point for European knowledge and knowledge transfer activity, a busy place where new biomedical research is making its mark and drawing from the scientific, humanistic and artistic culture that Barcelona offers as a European capital of the twenty-first century.

Scientific Advisory Board

SAB

Prof. Andrea Cavalli – University of Bologna and Italian Istitute of Tecnology

Prof. Imogen Coe – Ryerson University

Prof. Hannelore Daniel – Technical University of Munich

Dr. Martin Drysdale – Neophore, London

Dra. Mireia Gómez-Angelats – Novartis, Basel

Dr. Marçal Pastor-Anglada

Director

Dr. Carles Galdeano

Secretary

Permanent
commission

Dr. Bru Cormand
Dra. Carmen Escolano
Dra. Laura Herrero
Dr. Diego Muñoz-Torrero
Dr. Florenci Serras
Dr. Francesc Villarroya